| 17.8 2.73 (18.12%) | 03-06 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 22.99 | 1-year : | 26.7 |
| Resists | First : | 19.68 | Second : | 22.86 |
| Pivot price | 17.51  |
|||
| Supports | First : | 14.55 | Second : | 12.1 |
| MAs | MA(5) : | 15.87 |
MA(20) : | 18.34 |
| MA(100) : | 15.99 |
MA(250) : | 10.97 |
|
| MACD | MACD : | -0.7 |
Signal : | -0.4 |
| %K %D | K(14,3) : | 19.3 |
D(3) : | 12.7 |
| RSI | RSI(14): 51 |
|||
| 52-week | High : | 22.86 | Low : | 3.09 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ PRE ] has closed below upper band by 46.7%. Bollinger Bands are 84.8% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 9 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 18.37 - 18.5 | 18.5 - 18.6 |
| Low: | 15.87 - 15.99 | 15.99 - 16.09 |
| Close: | 17.63 - 17.83 | 17.83 - 17.99 |
Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; Circle Medical, a diagnostic testing product; and Circle One and F1x/Fem. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.
Fri, 06 Mar 2026
Prenetics Global (NASDAQ:PRE) to Repurchase $40.00 million in Outstanding Shares - MarketBeat
Fri, 06 Mar 2026
Prenetics stock surges after $40M buyback program announced - Investing.com
Fri, 06 Mar 2026
Prenetics Global Board Authorizes Share Repurchase Program - Nasdaq
Fri, 06 Mar 2026
Prenetics rises on $40M share buyback program - Seeking Alpha
Fri, 06 Mar 2026
Prenetics Authorizes $40 Million Share Repurchase Program - Bitget
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Diagnostics & Research
|
|
| Shares Out | 15 (M) |
| Shares Float | 12 (M) |
| Held by Insiders | 18.1 (%) |
| Held by Institutions | 13.9 (%) |
| Shares Short | 110 (K) |
| Shares Short P.Month | 96 (K) |
| EPS | -3.59 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 10.89 |
| Profit Margin | -63.2 % |
| Operating Margin | -33.3 % |
| Return on Assets (ttm) | -11.1 % |
| Return on Equity (ttm) | -31.8 % |
| Qtrly Rev. Growth | 248.6 % |
| Gross Profit (p.s.) | 3.2 |
| Sales Per Share | 6.05 |
| EBITDA (p.s.) | -2.17 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -23 (M) |
| Levered Free Cash Flow | -61 (M) |
| PE Ratio | -4.96 |
| PEG Ratio | 0 |
| Price to Book value | 1.63 |
| Price to Sales | 2.93 |
| Price to Cash Flow | -11.86 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|